Why is vision impaired in fragile X premutation carriers? The role of fragile X mental retardation protein and potential FMR1 mRNA toxicity

Neuroscience

Volumn 206, Issue , 2012, Pages 183-189

  Keri S ^a,b   Benedek, G ^a  

^a UNIVERSITY OF SZEGED   (Hungary)

^b National Psychiatry Center   (Hungary)

Author keywords

Fragile x syndrome; Neurodevelopment; Premutation carrier; RNA toxicity; Vision

Indexed keywords

FRAGILE X MENTAL RETARDATION PROTEIN; MESSENGER RNA;

ADULT; ARTICLE; BRAIN REGION; CLINICAL ARTICLE; CONTRAST SENSITIVITY; CONTROLLED STUDY; FMR1 GENE; FRAGILE X SYNDROME; GLOBAL FORM COHERENCE THRESHOLD; HUMAN; INHERITANCE; MAGNOCELLULAR NUCLEUS; MALE; MOTION COHERENCE THRESHOLD; PARVOCELLULAR NUCLEUS; PREMUTATION CARRIER; PRIORITY JOURNAL; PSYCHOPHYSICS; STRIATE CORTEX; VERNIER THRESHOLD; VISUAL IMPAIRMENT; VISUAL SYSTEM PARAMETERS;

ADULT; BLOTTING, SOUTHERN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FRAGILE X MENTAL RETARDATION PROTEIN; HETEROZYGOTE; HUMANS; MALE; RNA, MESSENGER; VISION, OCULAR; VISUAL PERCEPTION;

EID: 84857656692     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2012.01.005     Document Type: Article

References (45)

1. Banton T., Levi D.M. Spatial localization of motion-defined and luminance-defined contours. Vision Res 1993, 33:2225-2237.
2. Barlow H.B. Critical limiting factors in the design of the eye and the visual cortex. Proc R Soc Lond B Biol Sci 1981, 212:1-34.
3. Bear M.F., Dölen G., Osterweil E., Nagaraja N. Fragile X: translation in action. Neuropsychopharmacology 2008, 33:84-87.
4. Bennetto L., Pennington B.F., Porter D., Taylor A.K., Hagerman R.J. Profile of cognitive functioning in women with the fragile X mutation. Neuropsychology 2001, 15:290-299.
5. Berman R.F., Willemsen R. Mouse models of fragile X-associated tremor ataxia. J Investig Med 2009, 57:837-841.
6. Bourgeois J.A., Coffey S.M., Rivera S.M., Hessl D., Gane L.W., Tassone F., Greco C., Finucane B., Nelson L., Berry-Kravis E., Grigsby J., Hagerman P.J., Hagerman R.J. A review of fragile X premutation disorders: expanding the psychiatric perspective. J Clin Psychiatry 2009, 70:852-862.
7. Boyle L., Kaufmann W.E. The behavioral phenotype of FMR1 mutations. Am J Med Genet C Semin Med Genet 2010, 154C:469-476.
8. Cornish K., Kogan C., Turk J., Manly T., James N., Mills A., Dalton A. The emerging fragile X premutation phenotype: evidence from the domain of social cognition. Brain Cogn 2005, 57:53-60.
9. Cornish K.M., Kogan C.S., Li L., Turk J., Jacquemont S., Hagerman R.J. Lifespan changes in working memory in fragile X premutation males. Brain Cogn 2009, 69:551-558.
10. De Rubeis S., Bagni C. Regulation of molecular pathways in the fragile X syndrome: insights into autism spectrum disorders. J Neurodev Disord 2011, 3:257-269.
11. Duncan R.O., Boynton G.M. Cortical magnification within human primary visual cortex correlates with acuity thresholds. Neuron 2003, 38:659-671.
12. Farzin F., Whitney D., Hagerman R.J., Rivera S.M. Contrast detection in infants with fragile X syndrome. Vision Res 2008, 48:1471-1478.
13. Fatemi S.H., Folsom T.D. The role of fragile X mental retardation protein in major mental disorders. Neuropharmacology 2011, 60:1221-1226.
14. Franke P., Leboyer M., Hardt J., Sohne E., Weiffenbach O., Biancalana V.V., Cornillet-Lefebre P., Delobel B., Froster U., Schwab S.G., Poustka F., Hautzinger M., Maier W. Neuropsychological profiles of FMR-1 premutation and full-mutation carrier females. Psychiatry Res 1999, 87:223-231.
15. Glass L. The Moire effect from random dots. Nature 1969, 223:578-580.
16. Hagerman P.J., Hagerman R.J. Fragile X-associated tremor/ataxia syndrome (FXTAS). Ment Retard Dev Disabil Res Rev 2004, 10:25-30.
17. Hagerman R., Hoem G., Hagerman P. Fragile X and autism: intertwined at the molecular level leading to targeted treatments. Mol Autism 2010, 1:12.
18. Hagerman R.J., Staley L.W., O'Conner R., Lugenbeel K., Nelson D., McLean S.D., Taylor A. Learning-disabled males with a fragile X CGG expansion in the upper premutation size range. Pediatrics 1996, 97:122-126.
19. Hessl D., Wang J.M., Schneider A., Koldewyn K., Le L., Iwahashi C., Cheung K., Tassone F., Hagerman P.J., Rivera S.M. Decreased fragile X mental retardation protein expression underlies amygdala dysfunction in carriers of the fragile X premutation. Biol Psychiatry 2011, 70:859-865.
20. Hunter J.E., Rohr J.K., Sherman S.L. Co-occurring diagnoses among FMR1 premutation allele carriers. Clin Genet 2010, 77:374-381.
21. Iwahashi C., Tassone F., Hagerman R.J., Yasui D., Parrott G., Nguyen D., Mayeur G., Hagerman P.J. A quantitative ELISA assay for the fragile X mental retardation 1 protein. J Mol Diagn 2009, 11:281-289.
22. Kenneson A., Zhang F., Hagedorn C.H., Warren S.T. Reduced FMRP and increased FMR1 transcription is proportionally associated with CGG repeat number in intermediate-length and premutation carriers. Hum Mol Genet 2001, 10:1449-1454.
23. Kéri S., Benedek G. Visual pathway deficit in female fragile X premutation carriers: a potential endophenotype. Brain Cogn 2009, 69:291-295.
24. Kéri S., Benedek G. The perception of biological and mechanical motion in female fragile X premutation carriers. Brain Cogn 2010, 72:197-201.
25. Kéri S., Benedek G. Fragile X protein expression is linked to visual functions in healthy male volunteers. Neuroscience 2011, 192:345-350.
26. Kogan C.S., Boutet I., Cornish K., Zangenehpour S., Mullen K.T., Holden J.J., Der Kaloustian V.M., Andermann E., Chaudhuri A. Differential impact of the FMR1 gene on visual processing in fragile X syndrome. Brain 2004, 127:591-601.
27. Kogan C.S., Bertone A., Cornish K., Boutet I., Der Kaloustian V.M., Andermann E., Faubert J., Chaudhuri A. Integrative cortical dysfunction and pervasive motion perception deficit in fragile X syndrome. Neurology 2004, 63:1634-1639.
28. Ludwig A.L., Hershey J.W., Hagerman P.J. Initiation of translation of the FMR1 mRNA occurs predominantly through 5'-end-dependent ribosomal scanning. J Mol Biol 2011, 407:21-34.
29. McKendrick A.M., Badcock D.R., Gurgone M. Vernier acuity is normal in migraine, whereas global form and global motion perception are not. Invest Ophthalmol Vis Sci 2006, 47:3213-3219.
30. Moorem C.J., Daly E.M., Schmitz N., Tassone F., Tysoe C., Hagerman R.J., Hagerman P.J., Morris R.G., Murphy K.C., Murphy D.G. A neuropsychological investigation of male premutation carriers of fragile X syndrome. Neuropsychologia 2004, 42:1934-1947.
31. Nassi J.J., Callaway E.M. Parallel processing strategies of the primate visual system. Nat Rev Neurosci 2009, 10:360-372.
32. O'Donnell W.T., Warren S.T. A decade of molecular studies of fragile X syndrome. Annu Rev Neurosci 2002, 25:315-338.
33. Orban G.A., Van Essen D., Vanduffel W. Comparative mapping of higher visual areas in monkeys and humans. Trends Cogn Sci 2004, 8:315-324.
34. Qin M., Xia Z., Huang T., Smith C.B. Effects of chronic immobilization stress on anxiety-like behavior and basolateral amygdala morphology in Fmr1 knockout mice. Neuroscience 2011, 194:282-290.
35. Regan D. Form from motion parallax and form from luminance contrast: vernier discrimination. Spat Vis 1986, 1:305-318.
36. Rousseau F., Labelle Y., Bussières J., Lindsay C. The fragile X mental retardation syndrome 20 years after the FMR1 gene discovery: an expanding universe of knowledge. Clin Biochem Rev 2011, 32:135-162.
37. Steyaert J., Legius E., Borghgraef M., Fryns J.P. A distinct neurocognitive phenotype in female fragile-X premutation carriers assessed with visual attention tasks. Am J Med Genet A 2003, 116:44-51.
38. Tassone F., Hagerman R.J., Taylor A.K., Gane L.W., Godfrey T.E., Hagerman P.J. Elevated levels of FMR1 mRNA in carrier males: a new mechanism of involvement in the fragile-X syndrome. Am J Hum Genet 2000, 66:6-15.
39. Tootell R.B., Tsao D., Vanduffel W. Neuroimaging weighs in: humans meet macaques in "primate" visual cortex. J Neurosci 2003, 23:3981-3989.
40. Van Essen D.C., Gallant J.L. Neural mechanisms of form and motion processing in the primate visual system. Neuron 1994, 13:1-10.
41. Victor J.D., Conte M.M. Two-frequency analysis of interactions elicited by Vernier stimuli. Vis Neurosci 2000, 17:959-973.
42. Walter E., Mazaika P.K., Reiss A.L. Insights into brain development from neurogenetic syndromes: evidence from fragile X syndrome, Williams syndrome, Turner syndrome and velocardiofacial syndrome. Neuroscience 2009, 164:257-271.
43. Wechsler D. The Wechsler adult intelligence scale-III: administration and scoring manual 1997, The Psychological Corporation, San Antonio, TX.
44. Wilson H.R. Responses of spatial mechanisms can explain positional hyperacuity. Vision Res 1986, 26:453-469.
45. Zangenehpour S., Cornish K.M., Chaudhuri A. Whole-brain expression analysis of FMRP in adult monkey and its relationship to cognitive deficits in fragile X syndrome. Brain Res 2009, 1264:76-84.